Z2 is preparing in-depth white papers drawing on industrial experience in establishing biologics labs, cell line, media and upstream development. Planned topics include:
- Stability-led clone selection for complex antibody formats
- Developing media, feeds and process parameters together
- Building and qualifying predictive scale-down models
- Technology transfer: what a receiving site really needs
- Data, MVDA and AI/ML in upstream development
- Establishing biologics laboratories
To be notified when the first papers are published, get in touch or follow Z2 Biopharma on LinkedIn.
